Live Breaking News & Updates on Food Technologies Inc
Stay updated with breaking news from Food technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Provincial sales net revenue increased 31.7% to $7.9 million in Q4 2021 compared to $6.0 million in Q3 2021 Canada-wide provincial listings increased 21.0% to. ....
Provincial sales net revenue increased 31.7% to $7.9 million in Q4 2021 compared to $6.0 million in Q3 2021 Canada-wide provincial listings increa. ....
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis. ....
Cannabis Stocks In 2021 As marijuana stocks close the second week in May most leading cannabis stocks to invest in are showing some upside in the market. After the first-quarter rally in February top pot stocks have lost substantial value in the market. On the other hand, most cannabis companies continue delivering strong revenue gains and record earnings that should not be overlooked by investors. In the US the cannabis industry continues to show bullish potential in 2021. In April cannabis sales in Michigan increased by 149% to $153.8 million. Additionally, the top companies in the US have given some rather significant increases in revenue guidance for 2021. For the most part, this is currently being delivered by some of the top marijuana stocks to buy in their first-quarter results. It goes without saying the cannabis market has substantial growth potential for the next five years. But at the moment the cannabis sector seems to need a kick start from the US federal gove ....
Cannabis products producer The Valens Company Inc. (TSX:VLNS) (OTCQX:VLNCF) is poised to take over Green Roads in a cash-and-stock transaction. The M&A Deal: The Kelowna, British Columbia-based company agreed to purchase all issued and outstanding shares of Green Roads a U.S.-based, privately owned CBD company and its manufacturing subsidiary for $40 million. The price tag includes roughly $25.4 million in Valens common shares at an indicative price of $2.5088 per share and up to $14.6 million in cash. Under the terms of the agreement, Valens opted to pay an additional $20 million upon achieving certain EBITDA milestones in 2022. Stifel GMP is advising Valens throughout the sale process, while Stikeman Elliott LLP and Foley Hoag LLP act as legal counsel. Greenberg Traurig LLP agreed to act as legal counsel to Green Roads, and Cowen is acting as its exclusive financial advisor. ....